Meeting Highlights From CHMP, 19-22 February 2007 - Second Mock-up Pandemic Influenza Vaccine Receives Positive Opinion - Europe

Fri, 23 Feb 2007 08:00 PM EST

... The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorisation for Focetria, from Novartis Vaccines and Diagnostics S.r.l. Focetria is a mock-up pandemic influenza vaccine, intended for the prevention of influenza during an officially declared pandemic situation, once the pandemic viral strain has been included. [click link for full article] ...